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INTRODUCTION
Inflammatory myofibroblastic tumor (IMT) is a clinical
and pathological disease entity (1), which is an inflammatory
lesion with unknown etiology and usually originates from
the lung, but can also arise in any sites in the body (2). IMT
is used to denote a histologically similar group of tumors,
characterized by a spindle cell proliferation with a fibroinflam-
matory appearance that has been reported under a variety of
additional descriptive terms, such as atypical fibromyxoid
nodule, inflammatory fibroid polyp, inflammatory pseudo-
tumor, plasma cell granuloma, and pseudosarcomatous myofi-
broblastic proliferation (2, 3). We report a case of a 2-yr-old
boy who presented with fever of unknown origin and was
diagnosed with a gastric IMT. The clinical and histopatho-
logical features of this rare lesion are described with a review
of the previously reported cases. 
CASE REPORT
A 2-yr-old boy was referred to our emergency room because
of fever of unknown origin. According to his mother, he expe-
rienced intermittent fever of up to 39℃, preceded by shiv-
ering and followed by profuse sweating, together with poor
appetite for 6 weeks. The fever was alleviated by non-steroidal
anti-inflammatory drugs such as ibuprofen and acetamino-
phen. However, his body temperature gradually increased
again several hours later. The tuberculin skin test showed
weakly positive for Mycobacterium tuberculosis in another pedi-
atric clinic he was first admitted to. The body temperature
remained within normal range following antituberculous
medications including INH (isonicotinic acid hydrazid),
rifampicin, and pyrazinamide, however, fever developed 2
weeks later. He had no past history of serious illnesses, oper-
ations, or hospitalizations. 
On admission to our hospital, his anthropometry was be-
tween the 50th and 75th percentile. No abnormalities were
detected on physical examination except a fullness in the up-
per abdomen in deep palpation. Laboratory evaluation re-
vealed microcytic hypochromic anemia (hemoglobin, 10.5
g/dL; hematocrit, 33.3%; mean corpuscular volume, 68.8
fL), normal white blood cell count, eosinophilia (10%) and
thrombocytosis (695,000/ L). The erythrocyte sedimentation
rate (ESR) and C-reactive protein (CRP) were elevated at 116
mm/hr and 279 mg/L, respectively. Electrolytes, urinalyses,
and liver and renal function tests were normal. Widal-Wright
and Weil-Felix reactions, and serum markers for hepatitis B
and C and of human immunodeficiency viruses were all neg-
ative. Urinary vanillylmandelic acid (VMA) and homovanil-
lic acid (HVA) levels were normal. A culture of gastric juice
yielded a growth of Streptococcus viridans, but all other bacteri-
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Fever of Unknown Origin as a Presentation of Gastric Inflammatory
Myofibroblastic Tumor in a Two-Year-Old Boy
Gastric inflammatory myofibroblastic tumor (IMT) is an extremely rare lesion with
mimicking malignant features and accompanied with various clinical manifesta-
tions. Here we present a 2-yr-old boy who had a gastric IMT with a huge extra-
gastric mass, which closely resembled a neuroblastoma on imaging studies. He
experienced intermittent fever and poor appetite for 6 weeks. Fever remained
up to 38°C even on the operation day. He underwent partial gastrectomy and
distal pancreatectomy with splenectomy including the tumor. The preoperative
fever disappeared and did not recur in the postoperative course.
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ologic studies with throat swab, blood and urine specimens
were negative even for Mycobacterium tuberculosis. No pathogens
including parasites were recovered from stool. 
During hospitalization, the patient underwent ultrasono-
graphy (US) of the upper abdomen that showed a hypoechoic
lobulated mass lesion with irregular margin in the area of pan-
creas, measuring approximately 5×7 cm. This was confirmed
by abdominal computed tomography (CT) scan, which local-
ized the tumor to the left suprarenal and suprapancreatic re-
gion (Fig. 1). The mass displaced the left kidney, pancreas,
spleen, and stomach. The radiologist diagnosed the tumor as
adrenal neuroblastoma. Percutaneous sono-guided fine nee-
dle aspiration cytology of the mass showed a few clustering
and scattered spindle cells and some atypical cells with a high
N/C (nuclear/cytoplasmic) ratio in scanty cellular smear.
Fever remained up to 38℃even on the operation day. 
At laparotomy, an irregularly margined, round and rubbery
mass appeared to arise from the posterior gastric wall along
the greater curvature of the fundus and extend into the lesser
and greater sac; the mass was tightly adherent to the pancreas
along with splenic artery and hilar vessels of the spleen. The
mass was separated from the left adrenal gland but could not
be dissected from the pancreas and splenic hilum without
bleeding or injuries. For this reason, we performed partial
gastrectomy and distal pancreatectomy with splenectomy
including the tumor.
Gross examination of the primary tumor revealed an ill-
defined, smooth, glistening mass adherent to the anterior
surface of the pancreas and the hilum of the spleen with an
infiltration into the adjacent gastric wall. The excised tumor
measured 9×7×6 cm and weighed 270 g. Cut surfaces of
the primary tumor showed a whitish gray lobulated mass,
measuring 7.5×7 cm. The mass was well demarcated from
the normal pancreatic parenchyma and the splenic capsules
(Fig. 2). Histologically, the tumor was characterized by fibro-
Fig. 1. Transverse contrast-enhanced CT image of the upper ab-
domen reveals a large solid mass with inhomogeneous enhance-
ment (black solid arrows), displacing the stomach (open arrows)
anteriorly. The mass locates between the stomach and pancreas.  
Fig. 2. A large well-circumscribed solid and fibrous tumor is mea-
sured 7.5×7 cm. It is well demarcated from the normal pancreas
and spleen.
Fig. 3. The tumor cells are characterized by proliferation of spin-
dle-shaped atypical myofibroblastic cells and chronic inflamma-
tory cells including plasma cells and lymphocytes (H&E,×400).
5
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KUH 01-5229sis and proliferation of spindle cells. The tumor was princi-
pally composed of spindle or plump cells that had round or
elongated nuclei, prominent nucleoli with hypercellularity,
and mild nuclear atypism. Polymorphous inflammatory infil-
tration of plasma cells, histiocytes, and lymphocytes with
fibroblasts was also noted (Fig. 3). The pattern of growth
was infiltrative, with the whole thickness of the gastric wall
being infiltrated by the proliferating spindle cells. Immuno-
histochemically, the atypical tumor cells showed positive
immunoreactivity for vimentin and smooth muscle actin
protein, while stainings for desmin, myoglobin, and S-100
protein were negative.
The preoperative fever disappeared and did not recur in
the postoperative course. The patient was discharged with-
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Reference Age/sex Presentation Duration Operation Pathology
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Follow-up
Recurrence
Table 1. Clinical and pathological findings of gastric inflammatory myofibroblastic tumor in children
The question mark (?) signifies that there was no relevant description in the literature reviewed; *MH anemia: microcytic hypochromic anemia; 
� ESR:
erythrocyte sedimentation rate; 
� UGI bleeding: upper gastrointestinal bleeding; 
�GE reflux: gastroesophageal reflux; 
‖IMT: inflammatory myofibrob-
lastic tumor.
̃
̆out complication after vaccination for Streptococcus pneumoniae
and Hemophilus influenzae type b. The patient was clinically
well without evidence of recurrence during the 3 months after
the operation.
DISCUSSION
Inflammatory myofibroblastic tumor is a rare benign solid
tumor with an obscure etiology (4, 5). Despite an apparently
benign morphological nature, some cases of IMT have been
reported to have a malignant clinical course, such as a local-
ly aggressive growth and a tendency to recur after a complete
resection (5). It is usually difficult to confirm the accurate
diagnosis before operation (6, 7). Gastric IMT is also a very
rare tumor during childhood. To our knowledge based on the
available relevant literature, the present case is the first gastric
IMT throughout all ages in Korea. 
Clinical and pathological findings from a review of 13 cases
of gastric IMT in children that has been reported under a
variety of additional descriptive terms are summarized in
Table 1 (4, 8-16). Most cases were of less than 6-yr-old chil-
dren (92.3%) and females (69.2%). The clinical presentations
were variable such as weakness, fever, abdominal pain, upper
gastrointestinal bleeding, abdominal mass, weight loss, vom-
iting, poor appetite, gastroesophageal reflux, pallor, growth
retardation, and ascites, either single or in combination. Espe-
cially, three cases with fever as a main presentation showed
long durations of symptoms from 6 weeks to 6 months. In
our case, the cause of fever was not identified until the patient
underwent abdominal ultrasonography. Most cases (90.9%)
showed microcytic hypochromic anemia refractory to iron ther-
apy. Other laboratory features were an elevated ESR, throm-
bocytosis, eosinophilia, or hypergammaglobulinemia. In most
cases (87.5%), the diagnosis of IMT could not be confirmed
in preoperative workup. Despite the preoperative diagnostic
workups including ultrasonography, CT, endoscopy, or per-
cutaneous fine needle aspiration biopsy, it was difficult to
make an accurate preoperative diagnosis in this tumor. Some
tumors had extragastric extension to adhere or infiltrate to
the adjacent organs including the spleen, pancreas, and the
liver. In our case, we could not discriminate the margin of
tumor from the pancreas during the operation, although the
histopathology of tumor specimen revealed that the tumor
did not invade the pancreas or spleen. We performed partial
gastrectomy and distal pancreatectomy with splenectomy in-
cluding the tumor. Primary resection of the tumor was the
first treatment of choice in all cases reviewed and was gener-
ally successful except in 2 cases. 
The pathological diagnosis of IMT is based on the gross
and microscopic features. IMT is confirmed by the finding of
a stroma with mature spindle cells, often arranged in whorls
with fibrous bands. Mixed throughout the lesion is an inflam-
matory infiltration consisting predominantly of plasma cells
but often lymphocytes, histiocytes, and occasionally a small
component of acute inflammatory cells (17). Immunohisto-
logically, the spindle cells are reactive against antibodies to
vimentin, smooth muscle actin, and muscle-specific protein
in a majority of cases (2) as well as in ours. 
Most extrapulmonary IMT including gastric IMT are suc-
cessfully managed by surgical resection without development
of recurrence (3). Although the recurrence rate is seemingly
higher in the retroperitoneum, mesentery, and upper airway
(3), the prognosis of gastric IMT is usually good, as the out-
comes of the cases reviewed showed only 2 recurrences (9, 10)
out of 11 cases after surgery. The tendency for local recurrence
appears to be related to the initial site of the tumor in the ex-
trapulmonary IMT. Abdominal and sinonasal tumors appear
prone to recurrent and locally aggressive behavior (3). For
this reason, several authors recommended a complete surgi-
cal resection of the lesion as the first treatment of choice for
IMT (3, 7, 9, 18).
In conclusion, gastric IMT is an extremely rare lesion with
mimicking malignant features and accompanied with various
clinical manifestations. However, gastric IMT is a benign
lesion and surgically curable. Therefore, in order to avoid
unnecessary aggressive therapy, gastric IMT should be con-
sidered as the possible cause for a gastric mass in children ac-
companied with the various clinical manifestations and all
patients require a careful long-term follow-up because of the
risk of recurrence. 
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